Arunodhayan Sampath Sampathkumar

Mr. Arunodhayan Sampath Sampathkumar

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
ASArunodhayan Sampath Sampathkumar
Arunodhayan Sampath Sampathkumar
Tobias SchlosserTobias Schlosser
Tobias Schlosser
HLHolger Langner
Holger Langner
MRMarc Ritter
Marc Ritter
Danny KowerkoDanny Kowerko
Danny Kowerko
Optical coherence tomography (OCT)-based retinal imagery is often utilized to determine influential factors in patient progression and treatment, for which the retinal layers of the human eye are investigated to assess a patient’s health status and eyesight. In this contribution, we propose a machine learning (ML)-based multistage system of stacked multiscale encoders and decoders for the image segmentation of OCT imagery of the retinal layers to enable the following evaluation regarding the physiological and pathological states. Our proposed system’s results highlight its benefits compared to currently investigated approaches by combining commonly deployed methods from deep learning (DL) while utilizing deep neural networks (DNN). We conclude that by stacking multiple multiscale encoders and decoders, improved scores for the image segmentation task can be achieved. Our retinal-layer-based segmentation results in a final segmentation performance of up to 82.25±0.74% for the Sørensen–Dice coefficient, outperforming the current best single-stage model by 1.55% with a score of 80.70±0.20%, given the evaluated peripapillary OCT data set. Additionally, we provide results on the data sets Duke SD-OCT, Heidelberg, and UMN to illustrate our model’s performance on especially noisy data sets.

6 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Tobias SchlosserTobias Schlosser
Tobias Schlosser
FBFrederik Beuth
Frederik Beuth
TMTrixy Meyer
Trixy Meyer
ASArunodhayan Sampath Sampathkumar
Arunodhayan Sampath Sampathkumar
GSGabriel Stolze
Gabriel Stolze
Danny KowerkoDanny Kowerko
Danny Kowerko
In ophthalmology, intravitreal operative medication therapy (IVOM) is a widespread treatment for diseases related to the age-related macular degeneration (AMD), the diabetic macular edema, as well as the retinal vein occlusion. However, in real-world settings, patients often suffer from loss of vision on time scales of years despite therapy, whereas the prediction of the visual acuity (VA) and the earliest possible detection of deterioration under real-life conditions is challenging due to heterogeneous and incomplete data. In this contribution, we present a workflow for the development of a research-compatible data corpus fusing different IT systems of the department of ophthalmology of a German maximum care hospital. The extensive data corpus allows predictive statements of the expected progression of a patient and his or her VA in each of the three diseases. For the disease AMD, we found out a significant deterioration of the visual acuity over time. Within our proposed multistage system, we subsequently classify the VA progression into the three groups of therapy “winners”, “stabilizers”, and “losers” (WSL classification scheme). Our OCT biomarker classification using an ensemble of deep neural networks results in a classification accuracy (F1-score) of over 98%, enabling us to complete incomplete OCT documentations while allowing us to exploit them for a more precise VA modelling process. Our VA prediction requires at least four VA examinations and optionally OCT biomarkers from the same time period to predict the VA progression within a forecasted time frame, whereas our prediction is currently restricted to IVOM/no therapy. We achieve a final prediction accuracy of 69% in macro average F1-score, while being in the same range as the ophthalmologists with 57.8 and $$50 \pm 10.7$$ 50 ± 10.7 % F1-score.

30 December 2025 in bioRxiv
Verified
Preprint
Open access
YLYouhan Lee
Youhan Lee
SHShujun He
Shujun He
TOToshiyuki Oda
Toshiyuki Oda
GRG John Rao
G John Rao
YKYehyun Kim
Yehyun Kim
RDRhiju Das
Rhiju Das
Automatically predicting RNA 3D structure from sequence remains an unsolved challenge in biology and biotechnology. Here, we describe a Kaggle code competition engaging over 1700 teams and 43 previously unreleased structures to tackle this challenge. The top three submitted algorithms achieved scores within statistical error of the winners of the recent CASP16 competition. Unexpectedly, the top Kaggle strategy involved a pipeline for discovering 3D templates, without the use of deep learning. We integrated this template-modeling pipeline and other Kaggle strategies to develop a single model RNAPro that retrospectively outperformed individual Kaggle models on the same test set. These results suggest a growing importance of template-based modeling in RNA structure prediction.

21 May 2026 in Engineering Applications of Artificial Intelligence
Verified
Journal Article
Open access
TMTrixy Meyer
Trixy Meyer
Tobias SchlosserTobias Schlosser
Tobias Schlosser
SMSara Moniri
Sara Moniri
ASArunodhayan Sampath Sampathkumar
Arunodhayan Sampath Sampathkumar
MFMichael Friedrich
Michael Friedrich
Danny KowerkoDanny Kowerko
Danny Kowerko

28 January 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
ASArunodhayan Sampath Sampathkumar
Arunodhayan Sampath Sampathkumar
Danny KowerkoDanny Kowerko
Danny Kowerko
Generative Adversarial Networks (GANs) have emerged as powerful tools for medical image synthesis and clinical outcome prediction. In ophthalmology, accurate forecasting of Optical Coherence Tomography (OCT) images and best-corrected visual acuity (BCVA) values can significantly enhance patient monitoring and personalized treatment planning. We introduce a multimodal GAN inspired by the StyleGAN architecture, featuring super-resolution modules, a multi-scale patch discriminator, and temporal attention mechanisms. To predict logMAR values, a hybrid deep–shallow LSTM model was jointly trained alongside the image pipeline. Synthesized scans were processed through an EfficientNet-based classifier to predict 16 retinal biomarkers. To ensure subject independence, we employed a 3-fold patient-level cross-validation strategy. The proposed multimodal GAN achieved an SSIM of 0.9264, an FID of 11.9, and a PSNR of 38.1 dB for OCT forecasting. The logMAR module delivered an MAE of 0.052, while the biomarker classifier attained a macro-F1 score of 0.81. Based on logMAR change forecasting, patients were further categorized into Winner, Stabilizer, and Loser outcome groups using a threshold of Δ=0.05, achieving an overall F1 score of 0.84. Our approach effectively forecasts retinal morphology and functional outcomes, providing valuable predictive insights for proactive clinical decision-making in retinal health management.

27 March 2024 in arXiv
Verified
Preprint
Open access
PDF file
Tobias SchlosserTobias Schlosser
Tobias Schlosser
FBFrederik Beuth
Frederik Beuth
TMTrixy Meyer
Trixy Meyer
ASArunodhayan Sampath Sampathkumar
Arunodhayan Sampath Sampathkumar
GSGabriel Stolze
Gabriel Stolze
Danny KowerkoDanny Kowerko
Danny Kowerko
In ophthalmology, intravitreal operative medication therapy (IVOM) is a widespread treatment for diseases related to the age-related macular degeneration (AMD), the diabetic macular edema (DME), as well as the retinal vein occlusion (RVO). However, in real-world settings, patients often suffer from loss of vision on time scales of years despite therapy, whereas the prediction of the visual acuity (VA) and the earliest possible detection of deterioration under real-life conditions is challenging due to heterogeneous and incomplete data. In this contribution, we present a workflow for the development of a research-compatible data corpus fusing different IT systems of the department of ophthalmology of a German maximum care hospital. The extensive data corpus allows predictive statements of the expected progression of a patient and his or her VA in each of the three diseases. For the disease AMD, we found out a significant deterioration of the visual acuity over time. Within our proposed multistage system, we subsequently classify the VA progression into the three groups of therapy "winners", "stabilizers", and "losers" (WSL classification scheme). Our OCT biomarker classification using an ensemble of deep neural networks results in a classification accuracy (F1-score) of over 98 %, enabling us to complete incomplete OCT documentations while allowing us to exploit them for a more precise VA modelling process. Our VA prediction requires at least four VA examinations and optionally OCT biomarkers from the same time period to predict the VA progression within a forecasted time frame, whereas our prediction is currently restricted to IVOM / no therapy. We achieve a final prediction accuracy of 69 % in macro average F1-score, while being in the same range as the ophthalmologists with 57.8 and 50 +- 10.7 % F1-score.